Concerted activation of the Mdm2 promoter by p72 RNA helicase and the coactivators p300 and P/CAF

Journal of Cellular Biochemistry

Volumn 101, Issue 5, 2007, Pages 1252-1265

  Shin, Sook ^a   Janknecht, Ralf ^a  

^a MAYO CLINIC   (United States)

Author keywords

CBP; Mdm2; P CAF; p300; p72 RNA helicase; Transcription

Indexed keywords

HISTONE ACETYLTRANSFERASE PCAF; PROTEIN MDM2; PROTEIN P300; PROTEIN P72; RNA HELICASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANTIBODIES; ANTIBODY SPECIFICITY; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL NUCLEUS; CONSERVED SEQUENCE; DEAD-BOX RNA HELICASES; E1A-ASSOCIATED P300 PROTEIN; GENES, REPORTER; HISTONE ACETYLTRANSFERASES; HUMANS; LUCIFERASES; MATRIX METALLOPROTEINASE 7; MODELS, BIOLOGICAL; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-MDM2; TRANSCRIPTION FACTORS;

EID: 34547867046     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21250     Document Type: Article

References (64)

1. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM, Meltzer PS. 1997. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965-968.
2. Aratani S, Fujii R, Oishi T, Fujita H, Amano T, Ohshima T, Hagiwara M, Fukamizu A, Nakajima T. 2001. Dual roles of RNA helicase A in CREB-dependent transcription. Mol Cell Biol 21:4460-4469.
3. Bates GJ, Nicol SM, Wilson BJ, Jacobs AM, Bourdon JC, Wardrop J, Gregory DJ, Lane DP, Perkins ND, Fuller-Pace FV. 2005. The DEAD box protein p68: A novel transcriptional coactivator of the p53 tumour suppressor. EMBO J 24:543-553.
4. Bond GL, Hu W, Levine AJ. 2005. MDM2 is a central node in the p53 pathway: 12 years and counting. Curr Cancer Drug Targets 5:3-8.
5. Bosc DG, Janknecht R. 2002. Regulation of Her2/neu promoter activity by the ETS transcription factor, ER81. J Cell Biochem 86:174-183.
6. Bosc DG, Goueli BS, Janknecht R. 2001. HER2/Neumediated activation of the ETS transcription factor ER81 and its target gene MMP-1. Oncogene 20:6215-6224.
7. Brooks CL, Gu W. 2006. p53 ubiquitination: Mdm2 and beyond. Mol Cell 21:307-315.
8. Caruthers JM, McKay DB. 2002. Helicase structure and mechanism. Curr Opin Struct Biol 12:123-133.
9. Crawford HC, Fingleton B, Gustavson MD, Kurpios N, Wagenaar RA, Hassell JA, Matrisian LM. 2001. The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol Cell Biol 21:1370-1383.
10. De Haro L, Janknecht R. 2002. Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter. Nucleic Acids Res 30: 2972-2979.
11. De Haro L, Janknecht R. 2005. Cloning of the murine ER71 gene (Etsrp71) and initial characterization of its promoter. Genomics 85:493-502.
12. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. 1998. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17: 3091-3100.
13. Eisen A, Lucchesi JC. 1998. Unraveling the role of helicases in transcription. Bioessays 20:634-641.
14. Endoh H, Maruyama K, Masuhiro Y, Kobayashi Y, Goto M, Tai H, Yanagisawa J, Metzger D, Hashimoto S, Kato S. 1999. Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha. Mol Cell Biol 19:5363-5372.
15. Goel A, Janknecht R. 2003. Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu. Mol Cell Biol 23:6243-6254.
16. Goodman RH, Smolik S. 2000. CBP/p300 in cell growth, transformation, and development. Genes Dev 14:1553-1577.
17. Goueli BS, Janknecht R. 2003. Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor. Oncogene 22:8042-8047.
18. Goueli BS, Janknecht R. 2004. Upregulation of the catalytic telomerase subunit by the transcription factor ER81 and oncogenic HER2/Neu, Ras, or Raf. Mol Cell Biol 24:25-35.
19. Grossman SR. 2001. p300/CBP/p53 interaction and regulation of the p53 response. Eur J Biochem 268:2773-2778.
20. Gutman A, Wasylyk B. 1990. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 9:2241-2246.
21. Hönig A, Auboeuf D, Parker MM, O'Malley BW, Berget SM. 2002. Regulation of alternative splicing by the ATP-dependent DEAD-box RNA helicase p72. Mol Cell Biol 22:5698-5707.
22. Janknecht R. 1996. Analysis of the ERK-stimulated ETS transcription factor ER81. Mol Cell Biol 16:1550-1556.
23. Janknecht R. 2001. Cell type-specific inhibition of the ETS transcription factor ER81 by mitogen-activated protein kinase-activated protein kinase 2. J Biol Chem 276:41856-41861.
24. Janknecht R. 2002. The versatile functions of the transcriptional coactivators p300 and CBP and their roles in disease. Histol Histopathol 17:657-668.
25. Janknecht R. 2003. Regulation of the ER81 transcription factor and its coactivators by mitogen- and stress-activated protein kinase 1 (MSK1). Oncogene 22:746-755.
26. Janknecht R, Hunter T. 1996a. Transcription. A growing coactivator network. Nature 383:22-23.
27. Janknecht R, Hunter T. 1996b. Versatile molecular glue. Transcriptional control. Curr Biol 6:951-954.
28. Janknecht R, Hunter T. 1997. Convergence of MAP kinase pathways on the ternary complex factor Sap-1a. EMBO J 16:1620-1627.
29. Janknecht R, Nordheim A. 1993. Gene regulation by Ets proteins. Biochim Biophys Acta 1155:346-356.
30. Janknecht R, Ernst WH, Pingoud V, Nordheim A. 1993. Activation of ternary complex factor Elk-1 by MAP kinases. EMBO J 12:5097-5104.
31. Janknecht R, Cahill MA, Nordheim A. 1995. Signal integration at the c-fos promoter. Carcinogenesis 16:443-450.
32. Janknecht R, Wells NJ, Hunter T. 1998. TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300. Genes Dev 12:2114-2119.
33. Knebel J, De Haro L, Janknecht R. 2006. Repression of transcription by TSGA/Jmjd1a, a novel interaction partner of the ETS protein ER71. J Cell Biochem 99:319-329.
34. Lamm GM, Nicol SM, Fuller-Pace FV, Lamond AI. 1996. p72: A human nuclear DEAD box protein highly related to p68. Nucleic Acids Res 24:3739-3747.
35. Lanz RB, McKenna NJ, Onate SA, Albrecht U, Wong J, Tsai SY, Tsai MJ, O'Malley BW. 1999. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97.17-27.
36. Lee CG. 2002. RH70, a bidirectional RNA helicase, copurifies with U1snRNP. J Biol Chem 277:39679-39683.
37. Mantovani F, Banks L. 2001. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20:7874-7887.
38. Monte D, Coutte L, Baert JL, Angeli I, Stehelin D, de Launoit Y. 1995. Molecular characterization of the ets-related human transcription factor ER81. Oncogene 11:771-779.
39. Nakajima T, Uchida C, Anderson SF, Lee CG, Hurwitz J, Parvin JD, Montminy M. 1997. RNA helicase A mediates association of CBP with RNA polymerase II. Cell 90:1107-1112.
40. Ogilvie VC, Wilson BJ, Nicol SM, Morrice NA, Saunders LR, Barber GN, Fuller-Pace FV. 2003. The highly related DEAD box RNA helicases p68 and p72 exist as heterodimers in cells. Nucleic Acids Res 31:1470-1480.
41. Papoutsopoulou S, Janknecht R. 2000. Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300. Mol Cell Biol 20:7300-7310.
42. Patel JH, Du Y, Ard PG, Phillips C, Carella B, Chen CJ, Rakowski C, Chatterjee C, Lieberman PM, Lane WS, Blobel GA, McMahon SB. 2004. The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Mol Cell Biol 24:10826-10834.
43. Pause A, Sonenberg N. 1992. Mutational analysis of a DEAD box RNA helicase: The mammalian translation initiation factor eIF-4A. EMBO J 11:2643-2654.
44. Phelps M, Darley M, Primrose JN, Blaydes JP. 2003. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells. Cancer Res 63:2616-2623.
45. Puri PL, Sartorelli V, Yang XJ, Hamamori Y, Ogryzko W, Howard BH, Kedes L, Wang JY, Graessmann A, Nakatani Y, Levrero M. 1997. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell 1:35-45.
46. Rajendran RR, Nye AC, Frasor J, Balsara RD, Martini PG, Katzenellenbogen BS. 2003. Regulation of nuclear receptor transcriptional activity by a novel DEAD box RNA helicase (DP97). J Biol Chem 278:4628-4638.
47. Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T, McMahon M, Oren M, McCormick F. 2000. Opposing effects of Ras on p53: Transcriptional activation of mdm2 and induction of p19ARF. Cell 103:321-330.
48. Rocak S, Linder P. 2004. DEAD-box proteins: The driving forces behind RNA metabolism. Nat Rev Mol Cell Biol 5:232-241.
49. Rossow KL, Janknecht R. 2003. Synergism between p68 RNA helicase and the transcriptional coactivators CBP and p300. Oncogene 22:151-156.
50. Rössler OG, Straka A, Stahl H. 2001. Rearrangement of structured RNA via branch migration structures catalysed by the highly related DEAD-box proteins p68 and p72. Nucleic Acids Res 29:2088-2096.
51. Scolnick DM, Chehab NH, Stavridi ES, Lien MC, Caruso L, Moran E, Berger SL, Halazonetis TD. 1997. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res 57:3693-3696.
52. Silverman E, Edwalds-Gilbert G, Lin RJ. 2003. DExD/H-box proteins and their partners: Helping RNA helicases unwind. Gene 312:1-16.
53. Song CZ, Keller K, Murata K, Asano H, Stamatoyannopoulos G. 2002. Functional interaction between coactivators CBP/p300, PCAF, and transcription factor FKLF2. J Biol Chem 277:7029-7036.
54. Soutoglou E, Papafotiou G, Katrakili N, Talianidis I. 2000. Transcriptional activation by hepatocyte nuclear factor-1 requires synergism between multiple coactivator proteins. J Biol Chem 275:12515-12520.
55. Tanner NK, Linder P. 2001. DExD/H box RNA helicases: From generic motors to specific dissociation functions. Mol Cell 8:251-262.
56. Uhlmann-Schiffler H, Rossler OG, Stahl H. 2002. The mRNA of DEAD box protein p72 is alternatively translated into an 82-kDa RNA helicase. J Biol Chem 277:1066-1075.
57. Vervoorts J, Luscher-Firzlaff JM, Rottmann S, Lilischkis R, Walsemann G, Dohmann K, Austen M, Luscher B. 2003. Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep 4:484-490.
58. Wallberg AE, Pedersen K, Lendahl U, Roeder RG. 2002. p300 and PCAF act cooperatively to mediate transcriptional activation from chromatin templates by notch intracellular domains in vitro. Mol Cell Biol 22:7812-7819.
59. Watanabe M, Yanagisawa J, Kitagawa H, Takeyama K, Ogawa S, Arao Y, Suzawa M, Kobayashi Y, Yano T, Yoshikawa H, Masuhiro Y, Kato S. 2001. A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. EMBO J 20:1341-1352.
60. Westermarck J, Weiss C, Saffrich R, Kast J, Musti AM, Wessely M, Ansorge W, Seraphin B, Wilm M, Valdez BC, Bohmann D. 2002. The DEXD/H-box RNA helicase RHII/Gu is a co-factor for c-Jun-activated transcription. EMBO J 21:451-460.
61. Wilson BJ, Bates GJ, Nicol SM, Gregory DJ, Perkins ND, Fuller-Pace FV. 2004. The p68 and p72 DEAD box RNA helicases interact with HDAC1 and repress transcription in a promoter-specific manner. BMC Mol Biol 5:11.
62. Wu J, Janknecht R. 2002. Regulation of the ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1 and protein kinase A. J Biol Chem 277:42669-42679.
63. Yan X, Mouillet JF, Ou Q, Sadovsky Y. 2003. A novel domain within the DEAD-box protein DP103 is essential for transcriptional repression and helicase activity. Mol Cell Biol 23:414-423.
64. Yang XJ, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y. 1996. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319-324.